Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction

References

• AntmanEMHandMArmstrongPW2007Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the Canadian Cardiovascular Society Endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing CommitteeCirculation200811729632918071078
   PubMed Web of Science ®Google Scholar
• KeeleyECBouraJAGrinesCLPrimary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsLancet2003361132012517460
   PubMed Web of Science ®Google Scholar
• MelandriGPrimary angioplasty or thrombolysis for acute myocardial infarction?Lancet2003361966 author reply96796812648989
   PubMedGoogle Scholar
• DeMariaANLies, damned lies, and statisticsJ Am Coll Cardiol2008521430143118940535
   PubMed Web of Science ®Google Scholar
• BodenWEEagleKGrangerCBReperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction: A Comprehensive Review of Contemporary Management OptionsJ Am Coll Cardiol20075091792917765117
   PubMed Web of Science ®Google Scholar
• NallamothuBKBatesERHerrinJWangYBradleyEHKrumholzHMTimes to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysisCirculation200511176176715699253
   PubMed Web of Science ®Google Scholar
• JollisJGRoettigMLAlukoAOthe Reperfusion of Acute Myocardial Infarction in North Carolina Emergency Departments (RACE) InvestigatorsImplementation of a Statewide System for Coronary Reperfusion for ST-Segment Elevation Myocardial InfarctionJAMA20072982371238017982184
   PubMed Web of Science ®Google Scholar
• VakiliBAKaplanRBrownDLVolume-outcome relation for physicians and hospitals performing angioplasty for acute myocardial infarction in New York stateCirculation20011042171217611684626
   PubMed Web of Science ®Google Scholar
• BonnefoyELapostolleFLeizoroviczAPrimary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised studyLancet200236082582912243916
   PubMed Web of Science ®Google Scholar
• GaleCPMandaSOMBatinPDWestonCFBirkheadJSHallASPredictors of in-hospital mortality for patients admitted with ST-elevation myocardial infarction: a real-world study using the Myocardial Infarction National Audit Project (MINAP) databaseHeart2008941407141218070941
   PubMedGoogle Scholar
• PintoDSKirtaneAJNallamothuBKHospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategyCirculation20061142019202517075010
   PubMed Web of Science ®Google Scholar
• BatesERNallamothuBKCommentary: the role of percutaneous coronary intervention in ST-segment-elevation myocardial infarctionCirculation200811856757318663104
   PubMedGoogle Scholar
• ManariAOrtolaniPGuastarobaPClinical impact of an inter-hospital transfer strategy in patients with ST-elevation myocardial infarction undergoing primary angioplasty: the Emilia-Romagna ST-segment elevation acute myocardial infarction networkEur Heart J2008291834184218617475
   PubMedGoogle Scholar
• SabatineMSCannonCPGibsonCMthe CLARITY-TIMI 28 InvestigatorsAddition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment ElevationN Engl J Med20053521179118915758000
   PubMed Web of Science ®Google Scholar
• AntmanEMMorrowDAMcCabeCHthe ExTRACT-TIMI 25 InvestigatorsEnoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial InfarctionN Engl J Med20063541477148816537665
   PubMed Web of Science ®Google Scholar
• TsikourisJPTsikourisAPA review of available fibrin-specific thrombolytic agents used in acute myocardial infarctionPharmacotherapy20012120721711213858
   PubMed Web of Science ®Google Scholar
• ModiNBEpplerSBreedJCannonCPBraunwaldELoveTWPharmacokinetics of a slower clearing tissue plasminogen activator variant, TNK-tPA, in patients with acute myocardial infarctionThromb Haemost1998791341399459338
   PubMed Web of Science ®Google Scholar
• SerebruanyVMalininACallahanKEffect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: The Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudyAm Heart J200314563664212679759
   PubMed Web of Science ®Google Scholar
• CollenDStassenJMYasudaTComparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dogThromb Haemost199472981047974384
   PubMed Web of Science ®Google Scholar
• CannonCPMcCabeCHGibsonCMTNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trialCirculation1997953513569008448
   PubMed Web of Science ®Google Scholar
• CannonCPGibsonCMMcCabeCHTNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B InvestigatorsCirculation199898280528149860780
   PubMed Web of Science ®Google Scholar
• Van de WerfFCannonCPLuytenAHoubrackenKMcCabeCHBerioliSSafety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 InvestigatorsAm Heart J19991377869110220625
   PubMed Web of Science ®Google Scholar
• GiuglianoRPMcCabeCHAntmanEMCannonCPVan de WerfFWilcoxRGLower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhageAm Heart J200114174275011320361
   PubMed Web of Science ®Google Scholar
• Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Assessment of the Safety and Efficacy of a New Thrombolytic InvestigatorsLancet199935471672210475182
   PubMed Web of Science ®Google Scholar
• Van de WerfFBarronHVArmstrongPWIncidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PAEur Heart J2001222253226111728145
   PubMed Web of Science ®Google Scholar
• SinnaevePAAlexanderJBBelmansACOne-year follow-up of the ASSENT-2 trial: A double-blind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarctionAm Heart J2003146273212851604
   PubMed Web of Science ®Google Scholar
• Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 InvestigatorsEfficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarctionLancet200135860561311530146
   PubMed Web of Science ®Google Scholar
• AntmanEMLouwerenburgHWBaarsHFthe ENTIRE-TIMI 23 InvestigatorsEnoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 TrialCirculation20021051642164911940541
   PubMed Web of Science ®Google Scholar
• KaulPArmstrongPWCowperPAEconomic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarctionAm Heart J200514963764415990746
   PubMed Web of Science ®Google Scholar
• GiuglianoRPRoeMTHarringtonRACombination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: Results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic urialJ Am Coll Cardiol2003411251126012706917
   PubMed Web of Science ®Google Scholar
• TopolEJReperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trialLancet20013571905191411425410
   PubMed Web of Science ®Google Scholar
• WallentinLGoldsteinPArmstrongPWEfficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarctionCirculation200310813514212847070
   PubMed Web of Science ®Google Scholar
• ArmstrongPWChangWCWallentinLEfficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS dataCMAJ20061741421142616682709
   PubMed Web of Science ®Google Scholar
• Le MayMRWellsGALabinazMCombined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study)J Am Coll Cardiol20054641742416053952
   PubMed Web of Science ®Google Scholar
• Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigatorsPrimary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trialLancet200636756957816488800
   PubMed Web of Science ®Google Scholar
• ArmstrongPWWEST Steering CommitteeA comparison of pharmacologic therapy with/without timely coronary intervention vs primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) studyEur Heart J2006271530153816757491
   PubMed Web of Science ®Google Scholar
• Fernandez-AvilesFAlonsoJJPenaGPrimary angioplasty vs early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trialEur Heart J20072894996017244641
   PubMed Web of Science ®Google Scholar
• GibsonCMKarhaJGiuglianoRPAssociation of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarctionAm Heart J200414784785215131541
   PubMed Web of Science ®Google Scholar
• GoodmanSGMenonVCannonCPStegGOhmanEMHarringtonRAAcute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines8th EditionChest2008133708S775S18574277
   PubMedGoogle Scholar
• KallaKChristGKarnikRImplementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry)Circulation20061132398240516702474
   PubMed Web of Science ®Google Scholar
• TingHHRihalCSGershBJRegional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI ProtocolCirculation200711672973617673456
   PubMed Web of Science ®Google Scholar
• DanchinNCostePFerrieresJComparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI)Circulation200811826827618591434
   PubMedGoogle Scholar